Semi-chronic increase in striatal level of 3,4-dihydroxyphenylacetaldehyde does not result in alteration of nigrostriatal dopaminergic neurones

MLA

H. Legros, et al. “Semi-Chronic Increase in Striatal Level of 3,4-Dihydroxyphenylacetaldehyde Does Not Result in Alteration of Nigrostriatal Dopaminergic Neurones.” Journal of Neuroscience Research, vol. 75, Jan. 2004, pp. 429–35. EBSCOhost, https://doi.org/10.1002/jnr.10880.

APA

H. Legros, J.-J. Bonnet, Jean Costentin, Nathalie Dourmap, & François Janin. (2004). Semi-chronic increase in striatal level of 3,4-dihydroxyphenylacetaldehyde does not result in alteration of nigrostriatal dopaminergic neurones. Journal of Neuroscience Research, 75, 429–435. https://doi.org/10.1002/jnr.10880

Chicago

H. Legros, J.-J. Bonnet, Jean Costentin, Nathalie Dourmap, and François Janin. 2004. “Semi-Chronic Increase in Striatal Level of 3,4-Dihydroxyphenylacetaldehyde Does Not Result in Alteration of Nigrostriatal Dopaminergic Neurones.” Journal of Neuroscience Research 75 (January): 429–35. doi:10.1002/jnr.10880.